中国现代神经疾病杂志 ›› 2022, Vol. 22 ›› Issue (6): 445-449. doi: 10.3969/j.issn.1672-6731.2022.06.001

• 专论 • 上一篇    下一篇

2 脑静脉窦血栓形成血管内治疗现状与问题

莫大鹏1, 吕日琅2   

  1. 1 100070 首都医科大学附属北京天坛医院神经介入中心;
    2 712000 咸阳, 陕西省核工业二一五医院神经内科
  • 收稿日期:2022-06-18 出版日期:2022-06-25 发布日期:2022-07-01
  • 通讯作者: 吕日琅,Email:lvrilang@qq.com
  • 基金资助:
    北京市自然科学基金资助项目(项目编号:7172070)

Current status and problems of endovascular treatment for cerebral venous sinus thrombosis

MO Da-peng1, Lü Ri-lang2   

  1. 1 Department of Intervention Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing 100070, China;
    2 Department of Neurology, No. 215 Hospital of Shaanxi Nuclear Industry, Xianyang 712000, Shaanxi, China
  • Received:2022-06-18 Online:2022-06-25 Published:2022-07-01
  • Supported by:
    This study was supported by Natural Science Foundation of Beijing (No. 7172070).

摘要: 脑静脉窦血栓形成(CVST)是一种特殊的脑卒中类型,抗凝治疗是其主要治疗方式,但对于抗凝治疗无效的重症CVST患者,病死率较高,血管内治疗可改善此类患者预后。目前尚缺乏有关CVST血管内治疗的大型随机对照临床试验证据,血管内治疗的有效性和安全性值得商榷。本文概述近年来CVST血管内治疗的研究现状及存在问题,以指导临床实践。

关键词: 窦血栓形成,颅内, 脑静脉, 机械溶栓, 综述

Abstract: Cerebral venous sinus thrombosis (CVST) is a special type of stroke. At present, anticoagulant therapy is the main treatment, but the mortality rate is higher in severe patients with ineffective anticoagulant therapy, and endovascular treatment can improve the prognosis of these patients. However, there is a lack of large randomized controlled trials to verify the endovascular treatment of CVST currently, so the effectiveness and safety of endovascular treatment is questionable. This article is to analyze the current status and problems of endovascular treatment for CVST in recent years, in order to guide clinical practice.

Key words: Sinus thrombosis, intracranial, Cerebral veins, Mechanical thrombolysis, Review